Immune checkpoint inhibition: from molecules to clinical application

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Pages (from-to)	105-107
Number of pages	3
Journal	Clinical and Experimental Immunology
Volume	200
Issue number	2
DOIs	https://doi.org/10.1111/cei.13434
Publication status	Published - 1 May 2020

Access to Document

@article{b1f3b4c5d8584c22b41fcbb5f034eb42,

title = "Immune checkpoint inhibition: from molecules to clinical application",

author = "Taams, {L. S.} and {de Gruijl}, {T. D.}",

year = "2020",

month = may,

day = "1",

doi = "10.1111/cei.13434",

language = "English",

volume = "200",

pages = "105--107",

journal = "Clinical and Experimental Immunology",

issn = "0009-9104",

publisher = "Wiley-Blackwell",

number = "2",

}

TY - JOUR

T1 - Immune checkpoint inhibition

T2 - from molecules to clinical application

AU - Taams, L. S.

AU - de Gruijl, T. D.

PY - 2020/5/1

Y1 - 2020/5/1

UR - http://www.scopus.com/inward/record.url?scp=85083466407&partnerID=8YFLogxK

U2 - 10.1111/cei.13434

DO - 10.1111/cei.13434

M3 - Editorial

C2 - 32297327

AN - SCOPUS:85083466407

VL - 200

SP - 105

EP - 107

JO - Clinical and Experimental Immunology

JF - Clinical and Experimental Immunology

SN - 0009-9104

IS - 2

ER -